Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-01 4:14 pm Sale | 13D | KALVISTA PHARMACEUTICALS INC C KALV | TCG Crossover GP I LLC | 1,345,826 3.2% | -1,355,014 (-50.17%) | View |
| 2024-02-26 4:35 pm Purchase | 13G | KALVISTA PHARMACEUTICALS INC C KALV | ADAGE CAPITAL PARTNERS GP L.L.C. | 2,845,000 6.87% | 2,845,000 (New Position) | View |
| 2024-02-22 1:22 pm Purchase | 13D | KALVISTA PHARMACEUTICALS INC C KALV | Frazier Life Sciences Public Fund L.P. | 3,687,867 8.9% | 105,573 (+2.95%) | View |
| 2024-02-20 4:49 pm Sale | 13D | KALVISTA PHARMACEUTICALS INC C KALV | TCG Crossover GP I LLC | 2,700,840 6.52% | -707,241 (-20.75%) | View |
| 2024-02-14 8:52 pm Purchase | 13G | KALVISTA PHARMACEUTICALS INC C KALV | Venrock Healthcare Capital Partners III L.P. | 4,824,731 14% | 1,251,017 (+35.01%) | View |
| 2024-02-14 4:00 pm Purchase | 13G | KALVISTA PHARMACEUTICALS INC C KALV | TANG CAPITAL PARTNERS LP | 3,440,345 9.96% | 243,899 (+7.63%) | View |
| 2024-02-13 5:19 pm Purchase | 13G | KALVISTA PHARMACEUTICALS INC C KALV | SUVRETTA CAPITAL MANAGEMENT LLC | 2,684,005 7.8% | 887,626 (+49.41%) | View |
| 2024-02-13 5:07 pm Purchase | 13G | KALVISTA PHARMACEUTICALS INC C KALV | VANGUARD GROUP INC | 1,781,419 5.15% | 1,781,419 (New Position) | View |
| 2024-02-12 8:30 pm Purchase | 13G | KALVISTA PHARMACEUTICALS INC C KALV | Saturn V Capital Management LP | 1,431,259 4.1% | 1,431,259 (New Position) | View |
| 2024-02-09 09:16 am Sale | 13G | KALVISTA PHARMACEUTICALS INC C KALV | FMR LLC | 50,970 0.147% | -1,260,032 (-96.11%) | View |
| 2024-01-29 3:26 pm Purchase | 13G | KALVISTA PHARMACEUTICALS INC C KALV | BlackRock Inc. BLK | 2,242,025 6.5% | 669,604 (+42.58%) | View |
| 2023-12-28 4:16 pm Purchase | 13G | KALVISTA PHARMACEUTICALS INC C KALV | Venrock Healthcare Capital Partners III L.P. | 3,573,714 10.3% | 657,047 (+22.53%) | View |
| 2023-12-14 1:33 pm Purchase | 13D | KALVISTA PHARMACEUTICALS INC C KALV | Frazier Life Sciences Public Fund L.P. | 3,582,294 10.4% | 343,435 (+10.60%) | View |
| 2023-03-10 5:15 pm Purchase | 13G | KALVISTA PHARMACEUTICALS INC C KALV | SUVRETTA CAPITAL MANAGEMENT LLC | 1,796,379 5.3% | 724,077 (+67.53%) | View |
| 2023-02-14 4:59 pm Sale | 13G | KALVISTA PHARMACEUTICALS INC C KALV | GREAT POINT PARTNERS LLC | 1,055,801 3.1% | -224,199 (-17.52%) | View |
| 2023-02-14 4:00 pm Purchase | 13G | KALVISTA PHARMACEUTICALS INC C KALV | TANG CAPITAL PARTNERS LP | 3,196,446 9.4% | 1,796,446 (+128.32%) | View |
| 2023-02-14 08:41 am Sale | 13G | KALVISTA PHARMACEUTICALS INC C KALV | Deep Track Capital LP | 0 0% | -1,500,000 (Position Closed) | View |
| 2023-02-13 5:44 pm Purchase | 13G | KALVISTA PHARMACEUTICALS INC C KALV | Vivo Capital IX LLC | 772,068 2.3% | 772,068 (New Position) | View |
| 2023-02-13 10:51 am Sale | 13G | KALVISTA PHARMACEUTICALS INC C KALV | SUVRETTA CAPITAL MANAGEMENT LLC | 1,072,302 3.1% | -673,998 (-38.60%) | View |
| 2023-02-09 11:18 am Purchase | 13G | KALVISTA PHARMACEUTICALS INC C KALV | FMR LLC | 1,311,002 5.325% | 299,502 (+29.61%) | View |